Acute pain from trauma, burns and surgery is still managed with opioids and ketamine, despite their risks of respiratory depression, addiction and cognitive impairment—especially dangerous in emergency, battlefield and mass-casualty care. This report maps the non-addictive analgesic candidates now in development, the mechanisms behind them, and the patent landscape that shapes commercial opportunity.
Three pages from this report, open in full. The rest opens when you own it.
Eight parts, the same tabs you get when you own the report.
7 use cases
The technology recommended for each, with the alternatives.
+ 4 more
17 classes
Every class compared, with its patent trend and leading players.
+ 14 more
6 sectors
Mapped against the classes, with who sits in each.
Published November 2026 · © 2026 Berkeley FIT LLC. All rights reserved.
+ 3 more
56 companies
Searchable and filterable by sector, class and relevance.
+ 53 more
82 products
The products behind the companies, grouped by class.
+ 79 more
2,990 patents
Dominant and emerging holders for each mechanism of action.
+ 7 more
5 pathways
What each means for timelines and cost.
2 catalogs
Take the data with you.